Platinum-based chemotherapy regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Platinum-based chemotherapy regimen, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]